Related Experiment Video
Updated: Jun 30, 2025

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
NRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma
Shuming Hu1, Yuan Yuan2, Ruihan Yan1
1Department of Biochemistry & Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
NRF2 (NFE2L2) is a transcription factor mainly for regulating cellular antioxidant response and therefore promotes tumor progression. The target genes of NRF2 also play important roles in cellular processes including glucose metabolism, de novo serine synthesis, iron metabolism, etc. Here, by modulating NRF2 expression in lung adenocarcinoma (LUAD) cells, we showed that NRF2 regulated EGF expression at protein level. Furthermore, EGF was identified as a ubiquitinated protein. We predicted three deubiquitinases of EGF, and OTUD4 had the highest correlation with NRF2 in LUAD among the three. OTUD4 expression was reduced upon NRF2 knocking-down and recovered upon NRF2 rescuing in A549 cells. Then a potential binding site for NRF2 in OTUD4 promoter was searched out. By binding with OTUD4 promoter, NRF2 transcriptionally activated OTUD4, thus promoted EGF deubiquitination and enhanced its stability. More importantly, OTUD4 and NRF2 expression was found being correlated in LUAD patients. The data collectively revealed a novel mechanism of NRF2 regulating on EGF stability through OTUD4 in LUAD.
Insights
Nuclear factor erythroid 2-related factor 2 (NRF2) regulates Epidermal Growth Factor (EGF) stability in lung adenocarcinoma. NRF2 activates OTUD4, which deubiquitinates and stabilizes EGF, promoting tumor progression.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor crucial for cellular antioxidant response and tumor progression.
- NRF2 influences various cellular processes, including metabolism and biosynthesis, and its role in lung adenocarcinoma (LUAD) is significant.
Purpose of the Study:
- To elucidate the novel mechanism by which NRF2 regulates Epidermal Growth Factor (EGF) stability in lung adenocarcinoma.
- To investigate the role of deubiquitinases in the NRF2-EGF regulatory pathway.
Main Methods:
- Modulation of NRF2 expression in LUAD cells (A549).
- Identification and analysis of EGF ubiquitination status.
- Prediction and validation of deubiquitinase (OTUD4) interaction with NRF2.
- Analysis of NRF2 binding to the OTUD4 promoter and its transcriptional activation.
- Correlation analysis of NRF2 and OTUD4 expression in LUAD patient data.
Main Results:
- NRF2 modulates EGF expression at the protein level in LUAD cells.
- EGF was identified as a ubiquitinated protein, and OTUD4 showed the highest correlation with NRF2.
- NRF2 directly binds to the OTUD4 promoter, transcriptionally activating OTUD4 expression.
- Activated OTUD4 promotes EGF deubiquitination and enhances EGF stability.
- A significant correlation between OTUD4 and NRF2 expression was observed in LUAD patients.
Conclusions:
- NRF2 enhances EGF stability through the deubiquitinase OTUD4 in lung adenocarcinoma.
- This novel regulatory axis highlights a potential therapeutic target for LUAD treatment.
- The findings reveal a new mechanism linking NRF2, OTUD4, and EGF in cancer progression.
More Related Videos
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...